Chemical space and biology

Nature

Volumn 432, Issue 7019, 2004, Pages 824-828

  Dobson, Christopher M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DRUG PRODUCTS; MOLECULES;

BIOACTIVE MOLECULES; BIOLOGICAL PROCESSES; CHEMICAL SPACE;

BIOCHEMICAL ENGINEERING;

DRUG; NATURAL PRODUCT; NEW DRUG; PENICILLIN G;

BIOLOGY;

BIOLOGY; CHEMICAL GENETICS; COMBINATORIAL CHEMISTRY; DRUG COST; GENE SEQUENCE; HIGH THROUGHPUT SCREENING; HUMAN; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; SIDE EFFECT;

BIOCHEMISTRY; BIOLOGY; CELLS; CHEMISTRY, ORGANIC; DRUG DESIGN; HUMANS;

EID: 11144341956     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03192     Document Type: Review

References (44)

1. Fersht, A. R. Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding (W. H. Freeman, New York, 1999).
2. Bohacek, R. S., McMartin, C. & Guida, W. C. The art and practice of structure-based drug design: a molecular modelling perspective. Med. Res. Rev. 16, 3-50 (1996).
3. Luria, S. E., Gould, S. J. & Singer, S. A View of Life (Benjamin/Cummings, Menlo Park, California, 1981).
4. Goto, S., Okuno, Y., Hattori, M., Nishioka, T. & Kanehisa, M. LIGAND: database of chemical compounds and reactions in biological pathways. Nucleic Acids Res. 30, 402-404 (2002).
5. Lander E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 806-921 (2001).
6. Ellis R. J. & Minton, A. P. Join the crowd. Nature 425, 27-28 (2003).
7. Hall, D. & Minton, A. P. Macromolecular crowding: qualitative and semiquantitave successes, quantitative challenges. Biochim. Biophys. Acta. 1649, 127-139 (2003).
8. Voet, D. & Voet, J. G. Biochemistry 2nd edn (Wiley, New York, 1995).
9. Goodsell D. S. Inside a living cell. Trends Biochem. Sci. 16, 203-206 (1991).
10. Westerhoff, H. V. & Palsson, B. O. The evolution of molecular biology into systems biology. Nature Biotechnol. 22, 1249-1252 (2004).
11. Skår, J. & Coveney, P. V. Self-organization: the quest for the origin and evolution of structure. Phil. Trans. R. Soc. Lond. A 361, 1047-1317 (2003).
12. Tsien, R. Y. Imagining imaging's future. Nature Rev. Mol. Cell Biol. 4, SS16-SS21 (2003).
13. Medalia, O. et al. Macromolecular architecture in eukaryotic cells visualised by cryoelectron tomography. Science 298, 1209-1213 (2002).
14. Kitano, H. Computational systems biology. Nature 420, 206-210 (2001).
15. Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3-25 (1997).
16. Houghten, R. A. Parallel array and mixture-based synthetic combinatorial chemistry: tools for the next millenium. Annu. Rev. Pharmacol. Toxicol. 40, 273-282 (2000).
17. Schreiber, S. L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287, 1964-1969 (2000).
18. Bleicher, K. H. et al. Hit and lead generation: beyond high-throughput screening. Nature Rev. Drug Discov. 2, 369-378 (2003).
19. Feher, M. & Schmidt, J. M. Property distributions: differences between drugs, natural products and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci. 43, 218-227 (2003).
20. Service, R. F. Surviving the blockbuster syndrome. Science 303, 1796-1799 (2004).
21. Dickson, M. & Gagnon, J. P. Key factors in the rising cost of new drug discovery and development. Nature Rev. Drug Discov. 3, 417-429 (2004).
22. Mullin, R. Drug Discovery. Chem. Eng. News 82, 23-31 (2004).
23. Collins, F. S. et al., A vision for the future of genomics research. Nature 422, 835-847 (2003).
24. Zambrowicz, B. P. & Sands, A. T. Knockouts model the 100 best-selling drugs - will they model the next 100? Nature Rev. Drug Discov. 2, 38-51 (2003).
25. Hopkins, A. L. & Groom, C. R. The druggable genome. Nature Rev. Drug Discov. 1, 737-730 (2002).
26. Drews, J. Drug discovery: a historical perspective. Science 287, 1960-1964 (2000).
27. Newman, D. J., Cragg, G. M. & Snader, K. M. Natural products as a source of new drugs over the period 1981-2002. J. Nat. Prod. 66, 1002-1037 (2002).
28. Pace, N. R. A molecular view of microbial diversity and the biosphere. Science 276, 734-740 (1997).
29. Schreiber, S. L. Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg. Med. Chem. 6, 1127-1153 (1998).
30. Sills, M. A. et al. Comparison of assay technologies for a tyrosine kinase assay generates different results in high throughput screening. J. Biomol. Screening 7, 191-214 (2002).
31. Steitz, T. A. & Moore, P. B. RNA, the first macromolecular catalyst: the ribosome is a ribozyme. Trends Biochem. Sci. 28, 411-418 (2003).
32. Novina C. D. & Sharp, P. A. The RNAi revolution. Nature 430, 161-164 (2004).
33. Seeberger, P. H. Automated carbohydrate synthesis to drive chemical glycomics. Chem. Commun. 10, 1115-1121 (2003).
34. Buckingham, S. Bioinformatics: programmed for success. Nature 425, 209-215 (2003).
35. Agrafiotis, D. K., Lobanov, V. S. & Salemme, F. R. Combinatorial informatics in the post-genomics era. Nature Rev. Drug Discov. 1, 337-346 (2002).
36. Townsend J. A. et al. Chemical documents: machine understanding and automated information extraction. Org. Biomol. Chem. 22, 294-300 (2004).
37. Schreiber, S. L. The small-molecule approach to biology: chemical genetics and diversity-oriented organic synthesis make possible the systematic exploration of biology. Chem. Eng. News 81, 51-61 (2003).
38. Richardson, J. S. & Richardson, D. C. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl. Acad. Sci. USA 99, 2754-2759 (2002).
39. Dobson, C. M., Gerrard J. A. & Pratt, A. J. Foundations of Chemical Biology (Oxford Univ. Press, Oxford, 2001).
40. Nature insight: protein misfolding Nature 426, 883-909 (2003).
41. Dobson C. M. Protein folding and misfolding. Nature 426, 884-890 (2003).
42. Williams, R. J. P. & Frausto da Silva, J. J. R. The Natural Selection of the Chemical Elements (Oxford Univ. Press, Oxford, 1997).
43. Westheimer, F. H. Why nature chose phosphates. Science 235, 1173-1178 (1987).
44. Chin J. W. et al. An expanded eukaryotic genetic code. Science 301, 964-967 (2003).